{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:21:43Z","timestamp":1782800503612,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":433,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/mt.2015.91","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T11:21:59Z","timestamp":1432812119000},"page":"1401-1409","source":"Crossref","is-referenced-by-count":74,"title":["Long-term Outcome of Extranodal NK\/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs"],"prefix":"10.1016","volume":"23","author":[{"given":"Seok-Goo","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jung","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Kyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Taek","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Il","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Woo","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Eun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeongsin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Ock","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Whan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nak Gyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Wook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.91_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.91_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.91_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","article-title":"Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck","volume":"61","author":"Kim","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1038\/mt.2015.91_bib5","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.91_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","article-title":"Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia","volume":"99","author":"Yamaguchi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1038\/mt.2015.91_bib7","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1158\/1078-0432.CCR-12-1064","article-title":"Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Ito","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2015.91_bib8","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.91_bib9","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1182\/blood.V89.8.2966","article-title":"CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance","volume":"89","author":"Dr\u00e9nou","year":"1997","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib10","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1038\/mt.2015.91_bib11","first-page":"1063","article-title":"Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer\/T-cell lymphoma, nasal type","volume":"90","author":"Huang","year":"2005","journal-title":"Haematologica"},{"key":"10.1038\/mt.2015.91_bib12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jmv.20853","article-title":"Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK\/T-cell lymphoma","volume":"79","author":"Ishii","year":"2007","journal-title":"J Med Virol"},{"key":"10.1038\/mt.2015.91_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.1038\/mt.2015.91_bib15","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20040890","article-title":"Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease","volume":"200","author":"Bollard","year":"2004","journal-title":"J Exp Med"},{"key":"10.1038\/mt.2015.91_bib16","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-07-2975","article-title":"Treatment of nasopharyngeal carcinoma with Epstein-Barr virus\u2013specific T lymphocytes","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1532\/IJH97.A30505","article-title":"Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas","volume":"83","author":"Cho","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1038\/mt.2015.91_bib18","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood-2007-05-091280","article-title":"Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer","volume":"110","author":"Bollard","year":"2007","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2015.91_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(09)70265-7","article-title":"Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","author":"Kwong","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1038\/mt.2015.91_bib21","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","article-title":"How I treat NK\/T-cell lymphomas","volume":"121","author":"Tse","year":"2013","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1586\/era.10.130","article-title":"Risk stratification in extranodal natural killer\/T-cell lymphoma","volume":"10","author":"Kohrt","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1038\/mt.2015.91_bib23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bmt.1705349","article-title":"High-dose chemotherapy with autologous stem cell transplantation in extranodal NK\/T-cell lymphoma: a retrospective comparison with non-transplantation cases","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/mt.2015.91_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705244","article-title":"Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms","volume":"37","author":"Suzuki","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/mt.2015.91_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib26","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1182\/blood-2011-05-354142","article-title":"Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK\/T-cell lymphoma, nasal type","volume":"118","author":"Suzuki","year":"2011","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00277-010-1114-y","article-title":"Pilot study of pegylated interferon alpha-2a treatment during chemo- and radiotherapy and post-remission maintenance in patients with EBV-positive extranodal NK\/T cell lymphoma","volume":"90","author":"Kim","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1038\/mt.2015.91_bib28","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.4049\/jimmunol.0902850","article-title":"Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors","volume":"184","author":"Merlo","year":"2010","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.91_bib29","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","article-title":"Characterization of CD4(+) CTLs ex vivo","volume":"168","author":"Appay","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.91_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.91_bib31","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/leu.2013.66","article-title":"Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant","volume":"27","author":"Weber","year":"2013","journal-title":"Leukemia"},{"key":"10.1038\/mt.2015.91_bib32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1349-7006.2011.01974.x","article-title":"Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor models","volume":"102","author":"Park","year":"2011","journal-title":"Cancer Sci"},{"key":"10.1038\/mt.2015.91_bib33","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/blood.V93.9.3026","article-title":"Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood","volume":"93","author":"Chen","year":"1999","journal-title":"Blood"},{"key":"10.1038\/mt.2015.91_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/10428190210176","article-title":"Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis","volume":"43","author":"Teramura","year":"2002","journal-title":"Leuk Lymphoma"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:22:31Z","timestamp":1599074551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1525001616301757"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.91","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}